| IND | indomethacin; industrial medicine; investigational new drug |
|---|---|
| ind | indirect; induction |
| ref | ind refractive index |
| INT | intermediate; intermittent; intern, internship; internal; interval; intestinal; intima; p-iodonitrot... |
| Int | international; intestinal |
| IND | Indomethacin |
|---|---|
| IND | Intestinal Neuronal Dysplasia |
| IND | Investigational New Drug |
| IND | Investigational New Drug Application |
| INT | 4-iodonitrotetrazolium violet |
| ergon | <unit> A unit used to measure or represent the stability of a gene over the lifetime of a given organism. It is a function of the ratio of the adenine-thymine to the guanine-cytosine content of the gene, and is evidenced by the continual physical expression of the trait coded by the gene. (11 Nov 1997) |
|---|---|
| int 1 | <oncogene> Oncogene from mouse mammary carcinoma that encodes a secreted protein. Related to Drosophila gene wingless. (18 Nov 1997) |
| int 2 | <oncogene> Oncogene from mouse mammary carcinoma that encodes a member of fibroblast growth factor receptor family. (18 Nov 1997) |
| ind | Investigational New Drug An IND application containing laboratory study results of the drug candidate is submitted to the FDA to request permission to conduct studies in humans. (14 Nov 1997) |
| ind status | Status given an experimental drug after the FDA approves an application for testing it in people. (09 Oct 1997) |
| treatment ind | An FDA-approved program that allows a physician to procure an experimental drug for seriously ill patients who have no other treatment options in exchange for data on the safety and perhaps the effectiveness of the drug. See: compassionate use, parallel track, expanded access. (09 Oct 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|